ipilimumab,capecitabine,nivolumab,oxaliplatin,leucovorin,fluorouracil
bms
['biomarker', 'check,mate,649']
prior to the talk on biomarker analyses from the checkmate 649 trial during the #aacr23 session on novel immunotherapy combination clinical trials, check out the cancer discovery news in depth article covering some of this trial's earlier findings 
Follow Cancer Discovery for high-impact articles and news covering major advances in basic, translational, and clinical cancer research. Published by @AACR.